FUNDAMENTALS |
MarketCap: |
7.10 mill
|
EPS: |
0.0100
|
P/E: |
8.50
|
Earnings Date: |
May 08, 2024 |
SharesOutstanding: |
83.55 mill
|
Avg Daily Volume: |
0.0489 mill
|
RATINGS |
Rating CashFlow: |
Strong Sell
|
|
Return On Equity: |
Strong Buy
|
|
Return On Asset: |
Sell
|
|
DE: |
Strong Sell
|
|
P/E: |
Strong Sell
|
|
Price To Book: |
Strong Sell
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | | | n/a | n/a | n/a | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE 8.50 | sector: PE -11.58
|
PE RATIO: COMPANY / INDUSTRY |
0x
|
Company: PE 8.50 | industry: PE -6.92
|
DISCOUNTED CASH FLOW VALUE |
$-0.0011
(-101.34%)
$-0.0861
|
Date: 2024-05-04
|
Expected Trading Range (DAY) |
$ 0.0700 - 0.100
( +/- 17.65%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2015-08-01 | Merrell Keith L | Sell | 0 | Common Stock |
2023-11-07 | Robins Jeffrey Lynn | Buy | 200 000 | Common Stock |
2023-11-07 | Hayde William C | Buy | 1 000 000 | Common Stock |
2022-09-12 | Hayde William C | Sell | 0 | Common Stock |
2021-03-02 | Smith Wendy P. | Buy | 0 | Common Stock |
INSIDER POWER |
100.00
|
Last
14 transactions |
Buy:
2 000 000 | Sell:
2 000 000 |
Forecast:
16:00 - $0.0850
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.0850
Forecast 2: 16:00 - $0.0850
Forecast 3: 16:00 - $0.0850
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
Volume Signals |
Price |
$0.0850 (27.06% )
|
Volume |
0.0147 mill
|
Avg. Vol. |
0.0489 mill
|
% of Avg. Vol |
30.01 %
|
Signal 1: |
|
Signal 2: |
|
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NUMD
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.